Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02226874 · ClinicalTrials.gov registry record
Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 30
- Enrollment target
NCT02226874: Completed study, sponsored by National Cancer Institute (NCI).
NCT02226874 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02226874 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Background: \- The National Cancer Institute was funded to study how much radiation U.S. veterans who served in the 1950s were exposed to. Researchers want to estimate how much radiation these veterans received. They will use two methods and compare them. One is to interview the veterans and study their military records. The other is to take blood samples and look for certain types of changes in the blood cells. Being exposed to some kinds of radiation is known to cause changes in blood cells. The amount of changes to these cells tells scientists about how much radiation was received. Objectives: \- To better understand how to measure how much radiation a person has received. Eligibility: * Veterans who were exposed to radiation at a specific site in the Pacific in 1954 or other sites in the 1950s. * Veterans close in age to the first group, who have low levels of exposure to radiation. * Men about 25 years old with no exposure to radiation. Design: * Participants will have 1 visit, in their home. * All participants will have blood drawn. This will take 10 minutes. * The exposed veterans will be interviewed. They will answer questions about the nuclear events they experienced. This will take up to 40 minutes. * For the exposed veterans, researchers will look at their military records, if they can. They will estimate how much radiation the veteran received.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-08-26 |
| Est. Completion | 2016-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02226874
The ClinicalTrials.gov registry entry for NCT02226874 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02226874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02226874 about?
NCT02226874 is a clinical study titled "Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation". Background: \- The National Cancer Institute was funded to study how much radiation U.S. veterans who served in the 1950s were exposed to. Researchers want to estimate how much radiation these veterans received. They will use two methods and compare them. One is to interview the veterans and study ...
What is the current status of trial NCT02226874?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-08-26. Estimated completion is 2016-05-31.
Who is sponsoring clinical trial NCT02226874?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.